GLP-1 cravings – Misryoum reports on a pilot using GLP-1 medications to help reduce alcohol and drug cravings for women rebuilding their lives.
A new pilot program in Providence is betting on a surprising idea: that GLP-1 drugs, already used for diabetes and obesity, may help quiet the cravings that can drive people back to addiction.
Misryoum has been following the early results from OpenDoors. a nonprofit working with women recently released from prison or experiencing homelessness.. For participants. the GLP-1 approach is described less like a “high” and more like a reduction in the pull they feel toward alcohol and illicit drugs.. One participant. who once cycled through addiction despite building a stable life. says the medication helped her get through intense moments without acting on them.
What makes the pilot stand out is its focus on urges beyond opioids.. Traditional treatments for opioid use disorder are common. but alcohol and cocaine cravings are notoriously difficult to manage. especially for people facing unstable housing or limited support.. OpenDoors designed its program around that gap. inviting participants to take a weekly injection in a setting that prioritizes privacy and continuity of care.
Insight: This matters because cravings can be a daily battle, and if medication can reduce the mental pressure to use, it could change how relapse risk is understood and managed.
Misryoum reports that the pilot is being carried out with medical support from an addiction-focused physician and includes telehealth follow-ups.. Participants are also monitored for side effects, with early feedback pointing to limited issues, particularly around the start of treatment.. While weight and health improvements are among the better-known benefits of GLP-1 medications. the program’s attention is on whether cravings and “drug nightmares” ease enough to support longer-term recovery.
In the stories shared through the program. addiction is portrayed as an internal loop that keeps returning. even when someone wants to choose differently.. Another participant described drinking from the moment she woke up until night. struggling with pain and complicated mental health. and losing custody before finding a path into sober living and work.. In her account. the GLP-1 pilot helped reduce the immediate lure of alcohol. making it easier to move past triggering places and decisions.
Insight: The real shift here may not be willpower alone, but timing and momentum, since smaller barriers can help people rebuild routines and regain control of choices.
Both participants are nearing the end of their one-year involvement in the pilot. and the question of what happens next is now front and center.. Organizers say they intend to continue treatment for those who want it. while also expressing hope that wider approval and insurance coverage could expand access over time.. In their view. the broader stakes extend beyond individual recovery. touching the heavy social costs of addiction. including incarceration. family disruption. and lives lost.
Insight (final): If GLP-1s truly soften cravings for some people, it could open a new, practical doorway for treatment models that better fit real-world challenges like homelessness and limited resources.